Orawell&reg COVID-19 IgM/IgG Rapid Test

Instructions for Use:

Intended use

Orawell® COVID-19 IgM/IgG Rapid Test is based on Lateral Flow Immunoassay (LFI) intended for qualitative detection of IgM and IgG antibodies to SARS-CoV-2 in human whole blood (fingertip), serum or plasma. This test is for in vitro diagnostic use only.  It is intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection or a response to the COVID-19 vaccine. At this time, it is unknown how long antibodies persist after infection or vaccination and how long will protective immunity last.

Storage conditions

Test kit components

Test Cassette

Diluent

Lancet

Micropipette

Alcohol swab

Sample collection

Conducting the test

Understanding the test result

NEGATIVE

POSITIVE

INVALID RESULT

1. Negative Result: if the quality control mark “C” displays a colored line, and the test mark “IgG” or “IgM” is blank, then the test result is negative2. Positive result: if the quality control mark “C” and the test mark “IgG” both display colored lines, but the test mark “IgM” is blank, then the test result is positive for COVID-19 IgG antibodies

3. Positive result: if the quality control mark “C” and the test mark “IgM” both display colored lines, but the test mark “IgG” is blank, then the test result is positive for COVID-19 IgM antibodies

4. Positive result: if the quality control mark “C” and both the test mark “IgM” and “IgG” both display colored lines, then the test result is positive for both COVID-19 IgM and IgG antibodies

5. Invalid result: if the quality control mark “C” is blank, no matter whether the test mark for “IgM’ or “IgG” is colored or not, the test result is invalid